🔗 Permalink

Inventor profile of:

Katherine E. Henderson

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2013-10-17

Top Assignees for applications by Katherine E. Henderson

The entities that hold a legal rights for patent applications filed by inventor Henderson Katherine E.:

ZYMOGENETICS, INC. 4 Seattle, WA United States

Recent patent applications by Henderson Katherine E.

Katherine E. Henderson from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-10-17

US20130273000A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#2 | 2013-01-24

US20130022571A1

Human necessities

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

#3 | 2012-03-01

US20120053321A1

Chemistry; metallurgy

ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS

#4 | 2012-01-26

US20120020919A1

Human necessities

Use of IL-29 for treating a dengue virus infection

#5 | 2011-12-08

US20110300101A1

Human necessities

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

#6 | 2011-07-14

US20110171627A1

Chemistry; metallurgy

ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS

#7 | 2011-01-13

US20110008280A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#8 | 2010-11-25

US20100297068A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#9 | 2009-10-22

US20090263352A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#10 | 2009-01-15

US20090018080A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#11 | 2008-05-29

US20080124299A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#12 | 2008-03-27

US20080075693A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#13 | 2007-11-15

US20070264228A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#14 | 2007-07-26

US20070173445A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#15 | 2007-07-26

US20070172452A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#16 | 2007-07-26

US20070172451A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#17 | 2007-06-07

US20070128160A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#18 | 2007-03-29

US20070071721A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#19 | 2007-03-22

US20070065402A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#20 | 2007-03-22

US20070065401A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#21 | 2007-03-08

US20070053874A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#22 | 2007-03-01

US20070048262A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#23 | 2007-01-18

US20070015204A1

Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#24 | 2006-11-14

US10691923

Methods for treating viral infection using IL-28 and IL-29

#25 | 2005-11-03

US20050244423A1

Human necessities

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

InventorID:

52271 ⎘